Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. (2021)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14667
PubMed Identifier: 33217013
Publication URI: http://europepmc.org/abstract/MED/33217013
Type: Journal Article/Review
Volume: 87
Parent Publication: British journal of clinical pharmacology
Issue: 6
ISSN: 0306-5251